NORTH READING, Mass., May 4, 2017 /PRNewswire/ -- TraceLink Inc., the World's Largest Track and Trace Network for connectingthe life sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace, today announced financial and company results for the first quarter of 2017.
Growth highlights for the first quarter of 2017 include:
"Our commitment to investing and expanding globally was truly evidenced this quarter by the record sales growth in all regions, including EMEA, India and APAC," said Shabbir Dahod, president and CEO, TraceLink. "TraceLink's continuous growth and remarkable performance is a result of our global talent, superior market leadership and our ability to meet the industry's need for a proven, scalable solution that is seamless and cost-effective, while enabling timely compliance to meet serialization deadlines."
Also in the first quarter, TraceLink announced NEXUS 17, taking place June 7 – 8 in Barcelona. As the industry's premier venue for key industry leaders and stakeholders across the life sciences supply chain, NEXUS 17 will provide focused education and thought leadership from leading industry executives on the European Union Falsified Medicines Directive (EU FMD) and other global emerging track and trace regulations.
Additional growth highlights and milestones for the first quarter in 2017 include:
About TraceLinkTraceLink is the World's Largest Track and Trace Network for connecting the Life Sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace. Leading businesses trust the TraceLink Life Sciences Cloud to deliver complete global connectivity, visibility and traceability of pharmaceuticals from ingredient to patient. A single point and click connection to the Life Sciences Cloud creates a supply chain control tower that delivers the information, insight and collaboration needed to improve performance and reduce risk across global supply, manufacturing and distribution operations. A winner of numerous industry awards including Deloitte's Technology Fast 500 (ranked number 149 in 2016), the Amazon AWS Global Start-Up Challenge Grand Prize, and the Edison Award for Innovation in Health Management, the Life Sciences Cloud is used by businesses across the globe to meet strategic goals in ensuring global compliance, fighting drug counterfeiting, improving on-time and in-full delivery, protecting product quality and reducing operational cost. For more information on TraceLink and our solutions, visit www.tracelink.com or follow us on LinkedIn, Twitter and Facebook.
TraceLink is funded by Goldman Sachs, FirstMark Capital, Volition Capital and F-Prime Capital.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/tracelink-reports-highest-quarterly-revenue-and-record-breaking-growth-in-emea-new-sales-bookings-for-q1-2017-300451456.html
SOURCE TraceLink Inc.
Subscribe to our Free Newsletters!
Black food is the new green owing to its health benefits from cardiovascular health to weight loss. ...
Scurvy is a condition that occurs due to the deficiency of vitamin C. It occurs only rarely, since ...
Pets can give you diseases. Surprised? You may love your pet but beware! Your pets might be ...View All